GRCE
Price
$2.97
Change
+$0.03 (+1.02%)
Updated
Jun 27 closing price
Capitalization
41.07M
VTYX
Price
$2.35
Change
-$0.10 (-4.08%)
Updated
Jun 27 closing price
Capitalization
166.52M
38 days until earnings call
Interact to see
Advertisement

GRCE vs VTYX

Header iconGRCE vs VTYX Comparison
Open Charts GRCE vs VTYXBanner chart's image
Grace Therapeutics
Price$2.97
Change+$0.03 (+1.02%)
Volume$21.12K
Capitalization41.07M
Ventyx Biosciences
Price$2.35
Change-$0.10 (-4.08%)
Volume$9.45M
Capitalization166.52M
GRCE vs VTYX Comparison Chart in %
Loading...
GRCE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GRCE vs. VTYX commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GRCE is a Buy and VTYX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (GRCE: $2.97 vs. VTYX: $2.35)
Brand notoriety: GRCE and VTYX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GRCE: 57% vs. VTYX: 534%
Market capitalization -- GRCE: $41.07M vs. VTYX: $166.52M
GRCE [@Biotechnology] is valued at $41.07M. VTYX’s [@Biotechnology] market capitalization is $166.52M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GRCE’s FA Score shows that 0 FA rating(s) are green whileVTYX’s FA Score has 1 green FA rating(s).

  • GRCE’s FA Score: 0 green, 5 red.
  • VTYX’s FA Score: 1 green, 4 red.
According to our system of comparison, VTYX is a better buy in the long-term than GRCE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GRCE’s TA Score shows that 3 TA indicator(s) are bullish while VTYX’s TA Score has 2 bullish TA indicator(s).

  • GRCE’s TA Score: 3 bullish, 4 bearish.
  • VTYX’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, GRCE is a better buy in the short-term than VTYX.

Price Growth

GRCE (@Biotechnology) experienced а -1.00% price change this week, while VTYX (@Biotechnology) price change was +3.76% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

VTYX is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VTYX($167M) has a higher market cap than GRCE($41.1M). VTYX YTD gains are higher at: 7.078 vs. GRCE (-20.588). GRCE has higher annual earnings (EBITDA): -16.72M vs. VTYX (-135.48M). VTYX has more cash in the bank: 229M vs. GRCE (11.1M). GRCE (0) and VTYX (0) have equivalent revenues.
GRCEVTYXGRCE / VTYX
Capitalization41.1M167M25%
EBITDA-16.72M-135.48M12%
Gain YTD-20.5887.078-291%
P/E RatioN/AN/A-
Revenue00-
Total Cash11.1M229M5%
Total DebtN/A10.5M-
FUNDAMENTALS RATINGS
GRCE: Fundamental Ratings
GRCE
OUTLOOK RATING
1..100
61
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
PROFIT vs RISK RATING
1..100
46
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
51
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GRCEVTYX
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
85%
Bearish Trend 4 days ago
88%
Momentum
ODDS (%)
Bullish Trend 4 days ago
73%
Bearish Trend 4 days ago
89%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
87%
Bullish Trend 4 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 4 days ago
85%
Advances
ODDS (%)
N/A
Bullish Trend 18 days ago
85%
Declines
ODDS (%)
Bearish Trend 5 days ago
88%
Bearish Trend 14 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
79%
Aroon
ODDS (%)
Bullish Trend 4 days ago
72%
Bullish Trend 4 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
GRCE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UONE1.620.12
+8.00%
Urban One
DMRC13.190.39
+3.05%
Digimarc Corp
FAF61.231.41
+2.36%
First American Financial Corp
AMAT183.21-0.31
-0.17%
Applied Materials
MSC3.12-0.18
-5.47%
Studio City International Holdings Limited

GRCE and

Correlation & Price change

A.I.dvisor indicates that over the last year, GRCE has been loosely correlated with IMVT. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if GRCE jumps, then IMVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GRCE
1D Price
Change %
GRCE100%
+1.02%
IMVT - GRCE
42%
Loosely correlated
N/A
SLNO - GRCE
38%
Loosely correlated
-0.92%
CYTK - GRCE
37%
Loosely correlated
-2.21%
VTYX - GRCE
29%
Poorly correlated
-4.29%
CRNX - GRCE
27%
Poorly correlated
-0.10%
More

VTYX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTYX has been loosely correlated with KYMR. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if VTYX jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTYX
1D Price
Change %
VTYX100%
-4.29%
KYMR - VTYX
49%
Loosely correlated
-3.48%
SYRE - VTYX
49%
Loosely correlated
-4.99%
IMNM - VTYX
48%
Loosely correlated
-0.23%
NRIX - VTYX
46%
Loosely correlated
+0.17%
IPSC - VTYX
46%
Loosely correlated
-5.74%
More